InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,725.68
(
1.91%
)
US TECH 100
19,416.80
(
2.97%
)
Dow Jones
42,090.97
(
1.42%
)
Brent Oil
74.17
(
2.47%
)
Bitcoin
63,529.19
(
3.01%
)
Post# of 3061
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Whos_Who

Send PM Follow Ignore
Followers 15
Posts 1122
Boards Moderated 0
Alias Born 07/28/2014

Whos_Who

Re: None

Monday, 03/13/2017 9:30:36 PM

Monday, March 13, 2017 9:30:36 PM

Post# of 3061
Kin F. Chan, executive vice president of research and technology at BioPharmX,

"BPX-01 offers promise to millions of people who cannot take oral minocycline to treat their acne, including young children, pregnant women and the many people who are intolerant of systemic antibiotic treatments."

http://www.satprnews.com/2017/03/13/biopharmx-society-of-toxicology-poster-suggests-promise-of-bpx-01-as-topical-acne-therapy-highlights-safety/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up